Roflumilast 500 mcg Tablets for Respiratory Care
Roflumilast 500 mcg Tablets are an oral phosphodiesterase-4 (PDE4) inhibitor indicated as maintenance treatment for adults with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of frequent exacerbations. It helps reduce airway inflammation and lowers the risk of COPD flare-ups. Roflumilast is not a rescue medicine and should not be used to relieve sudden breathing attacks.
Benefits of Roflumilast 500 mcg
Helps reduce the frequency of COPD exacerbations.
Decreases airway inflammation.
Supports long-term lung function improvement.
Once-daily oral tablet for convenient maintenance therapy.
Suitable as an add-on treatment with bronchodilators in eligible patients.
Manufactured to international quality standards for global supply.
Dosage and Administration
To improve tolerability, some treatment guidelines recommend 250 mcg once daily for the first 4 weeks, followed by the maintenance dose of 500 mcg once daily. The tablet may be taken with or without food at the same time each day. Always use this medicine exactly as prescribed by a qualified healthcare professional.
Important Safety Information
Common side effects may include:
Diarrhea
Nausea
Headache
Weight loss
Reduced appetite
Insomnia
Patients should inform their healthcare provider about liver disease, depression, or significant weight loss before starting treatment.
Why Choose Cordium Pharmaceuticals?
Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter supplying high-quality respiratory medicines to international buyers.
Our advantages include:
WHO-GMP quality manufacturing
Export-ready documentation
Bulk supply for hospitals, pharmacies, distributors, and government tenders
Private labeling and customized packaging
Competitive international pricing
Reliable worldwide logistics support
Export Availability
Cordium Pharmaceuticals supplies Roflumilast 500 mcg Tablets to international markets including:
United States (USA): California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Michigan, Georgia.
United Kingdom (UK): England (London, Birmingham, Manchester), Scotland (Glasgow, Edinburgh), Wales (Cardiff), Northern Ireland (Belfast).
United Arab Emirates (UAE): Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah.
South Africa: Gauteng (Johannesburg, Pretoria), Western Cape (Cape Town), KwaZulu-Natal (Durban), Eastern Cape (Gqeberha), Free State (Bloemfontein).
These regions have significant demand for respiratory medicines because of the burden of COPD and chronic respiratory diseases.
Bulk Supply & International Distribution
Cordium Pharmaceuticals supports:
Pharmaceutical importers
Hospital procurement departments
Pharmacy chains
Healthcare distributors
Government healthcare tenders
International wholesalers
Contact Cordium Pharmaceuticals
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Roflumilast 500 mcg Tablets are an oral phosphodiesterase-4 (PDE4) inhibitor indicated as maintenance treatment for adults with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of frequent exacerbations. It helps reduce airway inflammation and lowers the risk of COPD flare-ups. Roflumilast is not a rescue medicine and should not be used to relieve sudden breathing attacks.
Benefits of Roflumilast 500 mcg
Helps reduce the frequency of COPD exacerbations.
Decreases airway inflammation.
Supports long-term lung function improvement.
Once-daily oral tablet for convenient maintenance therapy.
Suitable as an add-on treatment with bronchodilators in eligible patients.
Manufactured to international quality standards for global supply.
Dosage and Administration
To improve tolerability, some treatment guidelines recommend 250 mcg once daily for the first 4 weeks, followed by the maintenance dose of 500 mcg once daily. The tablet may be taken with or without food at the same time each day. Always use this medicine exactly as prescribed by a qualified healthcare professional.
Important Safety Information
Common side effects may include:
Diarrhea
Nausea
Headache
Weight loss
Reduced appetite
Insomnia
Patients should inform their healthcare provider about liver disease, depression, or significant weight loss before starting treatment.
Why Choose Cordium Pharmaceuticals?
Cordium Pharmaceuticals is a trusted Indian pharmaceutical exporter supplying high-quality respiratory medicines to international buyers.
Our advantages include:
WHO-GMP quality manufacturing
Export-ready documentation
Bulk supply for hospitals, pharmacies, distributors, and government tenders
Private labeling and customized packaging
Competitive international pricing
Reliable worldwide logistics support
Export Availability
Cordium Pharmaceuticals supplies Roflumilast 500 mcg Tablets to international markets including:
United States (USA): California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, North Carolina, Michigan, Georgia.
United Kingdom (UK): England (London, Birmingham, Manchester), Scotland (Glasgow, Edinburgh), Wales (Cardiff), Northern Ireland (Belfast).
United Arab Emirates (UAE): Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah.
South Africa: Gauteng (Johannesburg, Pretoria), Western Cape (Cape Town), KwaZulu-Natal (Durban), Eastern Cape (Gqeberha), Free State (Bloemfontein).
These regions have significant demand for respiratory medicines because of the burden of COPD and chronic respiratory diseases.
Bulk Supply & International Distribution
Cordium Pharmaceuticals supports:
Pharmaceutical importers
Hospital procurement departments
Pharmacy chains
Healthcare distributors
Government healthcare tenders
International wholesalers
Contact Cordium Pharmaceuticals
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
Keywords
